Pharmanutra S.p.A. (FRA:761)

Germany flag Germany · Delayed Price · Currency is EUR
62.80
-0.20 (-0.32%)
At close: Jan 30, 2026
25.10%
Market Cap605.96M +20.6%
Revenue (ttm)127.15M +12.7%
Net Income17.45M +7.2%
EPS1.82 +7.9%
Shares Outn/a
PE Ratio34.73
Forward PE28.28
Dividend1.00 (1.53%)
Ex-Dividend DateMay 5, 2025
Volume1
Average Volume25
Open62.30
Previous Close63.00
Day's Range62.30 - 62.80
52-Week Range38.55 - 67.10
Betan/a
RSI61.36
Earnings DateMar 13, 2026

About Pharmanutra

Pharmanutra S.p.A., a pharmaceutical and nutraceutical company, researches, designs, develops, and markets nutritional supplements and medical devices in Italy, Europe, the Middle East, South America, Far East, and internationally. The company produces and distributes raw materials and active ingredients for the food, pharmaceutical, and dietary supplement industries. It also offers iron deficiency, inflammation, mineral and vitamin, muscle and joint, sports nutrition, ophthalmic, and night rest products; and medical instrumentation and softwar... [Read more]

Industry Pharmaceutical Preparations
Founded 2003
Employees 136
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 761
Full Company Profile

Financial Performance

In 2024, Pharmanutra's revenue was 116.15 million, an increase of 15.33% compared to the previous year's 100.71 million. Earnings were 16.61 million, an increase of 29.43%.

Financial Statements